Merit Medical Appoints F. Ann Millner as Chair of the Board and Announces Projected Preliminary Unaudited Revenue Results for the Fourth Quarter of 2025

Core Viewpoint - Merit Medical Systems, Inc. has appointed Dr. F. Ann Millner as Chair of the Board following the resignation of Fred P. Lampropoulos, marking a significant leadership transition within the company [1][3][4]. Leadership Changes - Dr. Millner has been a director since 2015 and served as Lead Independent Director since July 2021, bringing extensive experience from her previous roles, including serving in the Utah State Senate and as President of Weber State University [2]. - Fred P. Lampropoulos resigned as a director and Chair of the Board on January 4, 2026, after concluding his role as Executive Chair on January 3, 2026, and his tenure as President and CEO on October 3, 2025 [3][4]. Company Performance - Preliminary unaudited revenue for the fourth quarter of 2025 is estimated to be between $389 million and $395 million, reflecting a year-over-year increase of approximately 10% to 11% [10]. - The constant currency revenue for the same period is projected to increase by approximately 8% to 10% year-over-year, indicating strong operational performance despite currency fluctuations [10][14]. Future Outlook - The company is focused on achieving its Continued Growth Initiatives and related financial targets for the three-year period ending December 31, 2026, emphasizing its commitment to delivering value to customers, employees, and shareholders [5]. - Merit plans to announce its financial results for the quarter and year ended December 31, 2025, and provide fiscal year 2026 guidance on February 24, 2026 [7].